Pharmaceutical Drugs Market Global Report 2017
出 版 商：TBRC
出版日期：2017/07/17
頁 數：250頁
文件格式：PDF
價 格：
USD 6,000 (Single-User License)
USD 9,000 (Multi-User License)
USD 12,000 (Global-User License)
USD 6,000 (Hard copy)
USD 9,000 (Multi-User License)
USD 12,000 (Global-User License)
USD 6,000 (Hard copy)
The Pharmaceutical Drugs Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global pharmaceutical drugs sector.
Reasons to Purchase
‧ Outperform competitors using accurate up to date demand-side dynamics information.
‧ Identify growth segments for investment.
‧ Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
‧ Create regional and country strategies on the basis of local data and analysis.
‧ Stay abreast of the latest customer and market research findings
‧ Benchmark performance against key competitors.
‧ Develop strategies based on likely future developments.
‧ Utilize the relationships between key data sets for superior strategizing.
‧ Suitable for supporting your internal and external presentations with reliable high quality data and analysis
‧ Gain a global perspective on the development of the market.
‧ Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the pharmaceutical drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider pharmaceuticals market, and compares it with other markets.
‧ The market characteristics section of the report defines and explains the market.
‧ The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
‧ Market segmentations break down market into sub markets.
‧ The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
‧ Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
‧ The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
‧ The pharmaceutical drugs market section of the report gives context. It compares the pharmaceutical drugs market with other segments of the pharmaceuticals market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Pharmaceutical Drugs Indicators Comparison.
‧ The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.
Scope
Markets Covered: Cardiovascular Disorders, Dermatology, Gastrointestinal Diseases, Genito-Urinary Disorders, Hematology, Infectious Diseases, Metabolic Disorders, Musculoskeletal Disorders, Central Nervous System, Oncology, Ophthalmology, Respiratory Diseases
Companies Mentioned: Johnson & Johnson, Novartis AG, F. Hoffmann-La Roche Ltd, Pfizer Inc., and Sanofi
Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Pharmaceutical Drugs Indicators Comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Reasons to Purchase
‧ Outperform competitors using accurate up to date demand-side dynamics information.
‧ Identify growth segments for investment.
‧ Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
‧ Create regional and country strategies on the basis of local data and analysis.
‧ Stay abreast of the latest customer and market research findings
‧ Benchmark performance against key competitors.
‧ Develop strategies based on likely future developments.
‧ Utilize the relationships between key data sets for superior strategizing.
‧ Suitable for supporting your internal and external presentations with reliable high quality data and analysis
‧ Gain a global perspective on the development of the market.
‧ Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the pharmaceutical drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider pharmaceuticals market, and compares it with other markets.
‧ The market characteristics section of the report defines and explains the market.
‧ The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
‧ Market segmentations break down market into sub markets.
‧ The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
‧ Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
‧ The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
‧ The pharmaceutical drugs market section of the report gives context. It compares the pharmaceutical drugs market with other segments of the pharmaceuticals market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Pharmaceutical Drugs Indicators Comparison.
‧ The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.
Scope
Markets Covered: Cardiovascular Disorders, Dermatology, Gastrointestinal Diseases, Genito-Urinary Disorders, Hematology, Infectious Diseases, Metabolic Disorders, Musculoskeletal Disorders, Central Nervous System, Oncology, Ophthalmology, Respiratory Diseases
Companies Mentioned: Johnson & Johnson, Novartis AG, F. Hoffmann-La Roche Ltd, Pfizer Inc., and Sanofi
Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Pharmaceutical Drugs Indicators Comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
1. Pharmaceutical Drugs Market Characteristics;
2. Pharmaceutical Drugs Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;
3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;
4. Pharmaceutical Drugs Market Customer Information;
5. Pharmaceutical Drugs Market Segmentation;
5.1. Global Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 5.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3. Global Pharmaceutical Drugs Market Trends And Strategies; 5.4. Global Pharmaceutical Drugs Market Compared With Similar Markets, 2016; 5.5. Global Pharmaceutical Drugs Market Compared With Similar Markets, 2012 – 2020, Historic and Forecast; 5.6. Pharmaceutical Drugs Market Compared With Similar Markets, 2016, By Region; 5.7. Pharmaceutical Drugs Market Compared With Similar Markets, 2016, By Country; 5.8. Cardiovascular Disorders; 5.8.1. Market Characteristics; 5.8.2. Global Cardiovascular Disorders Market, 2016, By Segment; 5.8.3. Market Trends And Strategies; 5.9. Dermatology; 5.9.1. Market Characteristics; 5.9.2. Global Dermatology Market, 2016, By Segment; 5.9.3. Market Trends And Strategies; 5.10. Gastrointestinal Diseases; 5.10.1. Market Characteristics; 5.10.2. Global Gastrointestinal Diseases Market, 2016, By Segment; 5.10.3. Market Trends And Strategies; 5.11. Genito-urinary Disorders; 5.11.1. Market Characteristics; 5.11.2. Global Genito-urinary Disorders Market, 2016, By Segment; 5.11.3. Market Trends And Strategies; 5.12. Hematology; 5.12.1. Market Characteristics; 5.12.2. Global Hematology Market, 2016, By Segment; 5.12.3. Market Trends And Strategies; 5.13. Infectious Diseases; 5.13.1. Market Characteristics; 5.13.2. Global Infectious Diseases Market, 2016, By Segment; 5.13.3. Market Trends And Strategies; 5.14. Metabolic Disorders; 5.14.1. Market Characteristics; 5.14.2. Global Metabolic Disorders Market, 2016, By Segment; 5.14.3. Market Trends And Strategies; 5.15. Musculoskeletal Disorders; 5.15.1. Market Characteristics; 5.15.2. Global Musculoskeletal Disorders Market, 2016, By Segment; 5.15.3. Market Trends And Strategies; 5.16. Central Nervous System; 5.16.1. Market Characteristics; 5.16.2. Global Central Nervous System Market, 2016, By Segment; 5.16.3. Market Trends And Strategies; 5.17. Oncology; 5.17.1. Market Characteristics; 5.17.2. Global Oncology Market, 2016, By Segment; 5.17.3. Market Trends And Strategies; 5.18. Ophthalmology; 5.18.1. Market Characteristics; 5.18.2. Global Ophthalmology Market, 2016, By Segment; 5.18.3. Market Trends And Strategies; 5.19. Respiratory Diseases; 5.19.1. Market Characteristics; 5.19.2. Global Respiratory Diseases Market, 2016, By Segment; 5.19.3. Market Trends And Strategies;
6. Pharmaceutical Drugs Market Regional And Country Analysis;
6.1. Global Pharmaceutical Drugs Market, 2016, By Region; 6.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. Pharmaceutical Drugs Market, 2016, By Country; 6.4. Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Healthcare Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Market Segments, 2016, By Region; 6.7. Global Healthcare Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Market Segments, 2016, By Country;
7. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors;
7.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global;
8. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries;
8.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country;
9. Pharmaceutical Drugs Market Comparison With Industry Metrics;
9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Pharmaceutical Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Pharmaceutical Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Average Spending On R&D/Product Development, 2016, By Country; 9.6. Global Pharmaceutical Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.8. Global Pharmaceutical Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.9. Global Number Of General Practitioners 2016, By Country; 9.10. Global Pharmaceutical Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country;
10. Asia-Pacific Pharmaceutical Drugs Market;
10.1.1. Asia-Pacific Pharmaceutical Drugs Market Overview; 10.1.2. Asia-Pacific Pharmaceutical Drugs Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific Pharmaceutical Drugs Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases10.2. Asia-Pacific Pharmaceutical Drugs Market: Country Analysis; 10.3. China Pharmaceutical Drugs Market; 10.3.1. China Pharmaceutical Drugs Market Overview; 10.3.2. China Pharmaceutical Drugs Historic Market, 2012 - 2016; 10.3.3. China Pharmaceutical Drugs Forecast Market, 2016 - 2020; 10.3.4. China Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases10.3.5. China Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020; 10.4. India Pharmaceutical Drugs Market; 10.4.1. India Pharmaceutical Drugs Market Overview; 10.4.2. India Pharmaceutical Drugs Historic Market, 2012 - 2016; 10.4.3. India Pharmaceutical Drugs Forecast Market, 2016 - 2020; 10.4.4. India Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases10.4.5. India Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020; 10.5. Japan Pharmaceutical Drugs Market; 10.5.1. Japan Pharmaceutical Drugs Market Overview; 10.5.2. Japan Pharmaceutical Drugs Historic Market, 2012 - 2016; 10.5.3. Japan Pharmaceutical Drugs Forecast Market, 2016 - 2020; 10.5.4. Japan Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 10.5.5. Japan Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020; 10.6. Australia Pharmaceutical Drugs Market; 10.6.1. Australia Pharmaceutical Drugs Historic Market, 2012 - 2016; 10.6.2. Australia Pharmaceutical Drugs Forecast Market, 2016 - 2020; 10.6.3. Australia Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 10.6.4. Australia Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020;
11. Western Europe Pharmaceutical Drugs Market;
11.1.1. Western Europe Pharmaceutical Drugs Market Overview; 11.1.2. Western Europe Pharmaceutical Drugs Historic Market, 2012 - 2016; 11.1.3. Western Europe Pharmaceutical Drugs Forecast Market, 2016 - 2020; 11.1.4. Western Europe Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.2. Western Europe Pharmaceutical Drugs Market: Country Analysis; 11.3. UK Pharmaceutical Drugs Market; 11.3.1. UK Pharmaceutical Drugs Market Overview; 11.3.2. UK Pharmaceutical Drugs Historic Market, 2012 - 2016; 11.3.3. UK Pharmaceutical Drugs Forecast Market, 2016 - 2020; 11.3.4. UK Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.3.5. UK Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 11.3.6. UK Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020; 11.4. Germany Pharmaceutical Drugs Market; 11.4.1. Germany Pharmaceutical Drugs Historic Market, 2012 - 2016; 11.4.2. Germany Pharmaceutical Drugs Forecast Market, 2016 - 2020; 11.4.3. Germany Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.4.4 Germany Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 11.4.5 Germany Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020; 11.5 France Pharmaceutical Drugs Market; 11.5.1 France Pharmaceutical Drugs Historic Market, 2012 - 2016; 11.5.2 France Pharmaceutical Drugs Forecast Market, 2016 - 2020; 11.5.3 France Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.5.4 France Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 11.5.5 France Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020; 11.6. Italy Pharmaceutical Drugs Market; 11.6.1. Italy Pharmaceutical Drugs Historic Market, 2012 - 2016; 11.6.2. Italy Pharmaceutical Drugs Forecast Market, 2016 - 2020; 11.6.3. Italy Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 11.6.4. Italy Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 11.6.5. Italy Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020; 11.7. Spain Pharmaceutical Drugs Market; 11.7.1. Spain Pharmaceutical Drugs Historic Market, 2012 - 2016; 11.7.2. Spain Pharmaceutical Drugs Forecast Market, 2016 - 2020; 11.7.3. Spain Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.7.4. Spain Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 11.7.5. Spain Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020;
12. Eastern Europe Pharmaceutical Drugs Market;
12.1.1. Eastern Europe Pharmaceutical Drugs Market Overview; 12.1.2. Eastern Europe Pharmaceutical Drugs Historic Market, 2012 - 2016; 12.1.3. Eastern Europe Pharmaceutical Drugs Forecast Market, 2016 - 2020; 12.1.4 Eastern Europe Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 12.2. Eastern Europe Pharmaceutical Drugs Market: Country Analysis; 12.3. Russia Pharmaceutical Drugs Market; 12.3. Russia Pharmaceutical Drugs Market; 12.3.1. Russia Pharmaceutical Drugs Historic Market, 2012 - 2016; 12.3.2. Russia Pharmaceutical Drugs Forecast Market, 2016 - 2020; 12.3.3. Russia Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 12.3.4. Russia Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 12.3.5. Russia Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020;
13. North America Pharmaceutical Drugs Market;
13.1.1. North America Pharmaceutical Drugs Market Overview; 13.1.2. North America Pharmaceutical Drugs Historic Market, 2012 - 2016; 13.1.3. North America Pharmaceutical Drugs Forecast Market, 2016 - 2020; 13.1.4. North America Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 13.2. North America Pharmaceutical Drugs Market: Country Analysis; 13.3. USA Pharmaceutical Drugs Market; 13.3.1. USA Pharmaceutical Drugs Historic Market, 2012 - 2016; 13.3.2. USA Pharmaceutical Drugs Forecast Market, 2016 - 2020; 13.3.3 USA Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases13.3.4. USA Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 13.3.5. USA Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020;
14. South America Pharmaceutical Drugs Market;
14.1.1. South America Pharmaceutical Drugs Market Overview; 14.1.2. South America Pharmaceutical Drugs Historic Market, 2012 - 2016; 14.1.3. South America Pharmaceutical Drugs Forecast Market, 2016 - 2020; 14.1.4. South America Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 14.2. South America Pharmaceutical Drugs Market: Country Analysis; 14.3. Brazil Pharmaceutical Drugs Market; 14.3.1. Brazil Pharmaceutical Drugs Historic Market, 2012 - 2016; 14.3.2. Brazil Pharmaceutical Drugs Forecast Market, 2016 - 2020; 14.3.3. Brazil Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 14.3.4. Brazil Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 14.3.5. Brazil Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020;
15. Middle East Pharmaceutical Drugs Market;
15.1.1. Middle East Pharmaceutical Drugs Market Overview; 15.1.2. Middle East Pharmaceutical Drugs Historic Market, 2012 - 2016; 15.1.3. Middle East Pharmaceutical Drugs Forecast Market, 2016 - 2020; 15.1.4. Middle East Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases;
16. Africa Pharmaceutical Drugs Market;
16.1.1. Africa Pharmaceutical Drugs Market Overview; 16.1.2. Africa Pharmaceutical Drugs Historic Market, 2012 - 2016; 16.1.3. Africa Pharmaceutical Drugs Forecast Market, 2016 - 2020; 16.1.4. Africa Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases;
17. Pharmaceutical Drugs Market Competitive Landscape;
17.1. Company Profiles; 17.2. Johnson & Johnson; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Novartis Ag; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. F. Hoffmann-La Roche Ltd; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Pfizer Inc.; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Sanofi; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;
18. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market;
19. Market Background: Pharmaceuticals Market;
19.1.1. Pharmaceuticals Market Characteristics; 19.1.2. Pharmaceuticals Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceuticals Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceuticals Trends And Strategies; 19.2. Pharmaceuticals Market Regional And Country Analysis; 19.2.1. Global Pharmaceuticals Market, 2016, By Region; 19.2.2. Pharmaceuticals Market, 2016, By Country; 19.2.3. Pharmaceuticals Market, 2012 - 2020, Historic And Forecast, By Country; 19.2.4. Global Pharmaceuticals Market, Growth And Market Share Comparison, By Segment; 19.2.5. Global Pharmaceuticals Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Pharmaceuticals Market Comparison With Macro Economic Factors; 19.3.1. Pharmaceuticals Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Pharmaceuticals Expenditure, Global; 19.4. Pharmaceuticals Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceuticals Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceuticals Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceuticals Market;
20. Healthcare Industry Financial Margins;
21. Appendix;
21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer
2. Pharmaceutical Drugs Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;
3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;
4. Pharmaceutical Drugs Market Customer Information;
5. Pharmaceutical Drugs Market Segmentation;
5.1. Global Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 5.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3. Global Pharmaceutical Drugs Market Trends And Strategies; 5.4. Global Pharmaceutical Drugs Market Compared With Similar Markets, 2016; 5.5. Global Pharmaceutical Drugs Market Compared With Similar Markets, 2012 – 2020, Historic and Forecast; 5.6. Pharmaceutical Drugs Market Compared With Similar Markets, 2016, By Region; 5.7. Pharmaceutical Drugs Market Compared With Similar Markets, 2016, By Country; 5.8. Cardiovascular Disorders; 5.8.1. Market Characteristics; 5.8.2. Global Cardiovascular Disorders Market, 2016, By Segment; 5.8.3. Market Trends And Strategies; 5.9. Dermatology; 5.9.1. Market Characteristics; 5.9.2. Global Dermatology Market, 2016, By Segment; 5.9.3. Market Trends And Strategies; 5.10. Gastrointestinal Diseases; 5.10.1. Market Characteristics; 5.10.2. Global Gastrointestinal Diseases Market, 2016, By Segment; 5.10.3. Market Trends And Strategies; 5.11. Genito-urinary Disorders; 5.11.1. Market Characteristics; 5.11.2. Global Genito-urinary Disorders Market, 2016, By Segment; 5.11.3. Market Trends And Strategies; 5.12. Hematology; 5.12.1. Market Characteristics; 5.12.2. Global Hematology Market, 2016, By Segment; 5.12.3. Market Trends And Strategies; 5.13. Infectious Diseases; 5.13.1. Market Characteristics; 5.13.2. Global Infectious Diseases Market, 2016, By Segment; 5.13.3. Market Trends And Strategies; 5.14. Metabolic Disorders; 5.14.1. Market Characteristics; 5.14.2. Global Metabolic Disorders Market, 2016, By Segment; 5.14.3. Market Trends And Strategies; 5.15. Musculoskeletal Disorders; 5.15.1. Market Characteristics; 5.15.2. Global Musculoskeletal Disorders Market, 2016, By Segment; 5.15.3. Market Trends And Strategies; 5.16. Central Nervous System; 5.16.1. Market Characteristics; 5.16.2. Global Central Nervous System Market, 2016, By Segment; 5.16.3. Market Trends And Strategies; 5.17. Oncology; 5.17.1. Market Characteristics; 5.17.2. Global Oncology Market, 2016, By Segment; 5.17.3. Market Trends And Strategies; 5.18. Ophthalmology; 5.18.1. Market Characteristics; 5.18.2. Global Ophthalmology Market, 2016, By Segment; 5.18.3. Market Trends And Strategies; 5.19. Respiratory Diseases; 5.19.1. Market Characteristics; 5.19.2. Global Respiratory Diseases Market, 2016, By Segment; 5.19.3. Market Trends And Strategies;
6. Pharmaceutical Drugs Market Regional And Country Analysis;
6.1. Global Pharmaceutical Drugs Market, 2016, By Region; 6.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. Pharmaceutical Drugs Market, 2016, By Country; 6.4. Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Healthcare Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Market Segments, 2016, By Region; 6.7. Global Healthcare Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Market Segments, 2016, By Country;
7. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors;
7.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global;
8. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries;
8.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country;
9. Pharmaceutical Drugs Market Comparison With Industry Metrics;
9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Pharmaceutical Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Pharmaceutical Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Average Spending On R&D/Product Development, 2016, By Country; 9.6. Global Pharmaceutical Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.8. Global Pharmaceutical Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.9. Global Number Of General Practitioners 2016, By Country; 9.10. Global Pharmaceutical Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country;
10. Asia-Pacific Pharmaceutical Drugs Market;
10.1.1. Asia-Pacific Pharmaceutical Drugs Market Overview; 10.1.2. Asia-Pacific Pharmaceutical Drugs Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific Pharmaceutical Drugs Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases10.2. Asia-Pacific Pharmaceutical Drugs Market: Country Analysis; 10.3. China Pharmaceutical Drugs Market; 10.3.1. China Pharmaceutical Drugs Market Overview; 10.3.2. China Pharmaceutical Drugs Historic Market, 2012 - 2016; 10.3.3. China Pharmaceutical Drugs Forecast Market, 2016 - 2020; 10.3.4. China Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases10.3.5. China Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020; 10.4. India Pharmaceutical Drugs Market; 10.4.1. India Pharmaceutical Drugs Market Overview; 10.4.2. India Pharmaceutical Drugs Historic Market, 2012 - 2016; 10.4.3. India Pharmaceutical Drugs Forecast Market, 2016 - 2020; 10.4.4. India Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases10.4.5. India Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020; 10.5. Japan Pharmaceutical Drugs Market; 10.5.1. Japan Pharmaceutical Drugs Market Overview; 10.5.2. Japan Pharmaceutical Drugs Historic Market, 2012 - 2016; 10.5.3. Japan Pharmaceutical Drugs Forecast Market, 2016 - 2020; 10.5.4. Japan Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 10.5.5. Japan Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020; 10.6. Australia Pharmaceutical Drugs Market; 10.6.1. Australia Pharmaceutical Drugs Historic Market, 2012 - 2016; 10.6.2. Australia Pharmaceutical Drugs Forecast Market, 2016 - 2020; 10.6.3. Australia Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 10.6.4. Australia Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020;
11. Western Europe Pharmaceutical Drugs Market;
11.1.1. Western Europe Pharmaceutical Drugs Market Overview; 11.1.2. Western Europe Pharmaceutical Drugs Historic Market, 2012 - 2016; 11.1.3. Western Europe Pharmaceutical Drugs Forecast Market, 2016 - 2020; 11.1.4. Western Europe Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.2. Western Europe Pharmaceutical Drugs Market: Country Analysis; 11.3. UK Pharmaceutical Drugs Market; 11.3.1. UK Pharmaceutical Drugs Market Overview; 11.3.2. UK Pharmaceutical Drugs Historic Market, 2012 - 2016; 11.3.3. UK Pharmaceutical Drugs Forecast Market, 2016 - 2020; 11.3.4. UK Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.3.5. UK Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 11.3.6. UK Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020; 11.4. Germany Pharmaceutical Drugs Market; 11.4.1. Germany Pharmaceutical Drugs Historic Market, 2012 - 2016; 11.4.2. Germany Pharmaceutical Drugs Forecast Market, 2016 - 2020; 11.4.3. Germany Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.4.4 Germany Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 11.4.5 Germany Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020; 11.5 France Pharmaceutical Drugs Market; 11.5.1 France Pharmaceutical Drugs Historic Market, 2012 - 2016; 11.5.2 France Pharmaceutical Drugs Forecast Market, 2016 - 2020; 11.5.3 France Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.5.4 France Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 11.5.5 France Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020; 11.6. Italy Pharmaceutical Drugs Market; 11.6.1. Italy Pharmaceutical Drugs Historic Market, 2012 - 2016; 11.6.2. Italy Pharmaceutical Drugs Forecast Market, 2016 - 2020; 11.6.3. Italy Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 11.6.4. Italy Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 11.6.5. Italy Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020; 11.7. Spain Pharmaceutical Drugs Market; 11.7.1. Spain Pharmaceutical Drugs Historic Market, 2012 - 2016; 11.7.2. Spain Pharmaceutical Drugs Forecast Market, 2016 - 2020; 11.7.3. Spain Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.7.4. Spain Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 11.7.5. Spain Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020;
12. Eastern Europe Pharmaceutical Drugs Market;
12.1.1. Eastern Europe Pharmaceutical Drugs Market Overview; 12.1.2. Eastern Europe Pharmaceutical Drugs Historic Market, 2012 - 2016; 12.1.3. Eastern Europe Pharmaceutical Drugs Forecast Market, 2016 - 2020; 12.1.4 Eastern Europe Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 12.2. Eastern Europe Pharmaceutical Drugs Market: Country Analysis; 12.3. Russia Pharmaceutical Drugs Market; 12.3. Russia Pharmaceutical Drugs Market; 12.3.1. Russia Pharmaceutical Drugs Historic Market, 2012 - 2016; 12.3.2. Russia Pharmaceutical Drugs Forecast Market, 2016 - 2020; 12.3.3. Russia Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 12.3.4. Russia Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 12.3.5. Russia Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020;
13. North America Pharmaceutical Drugs Market;
13.1.1. North America Pharmaceutical Drugs Market Overview; 13.1.2. North America Pharmaceutical Drugs Historic Market, 2012 - 2016; 13.1.3. North America Pharmaceutical Drugs Forecast Market, 2016 - 2020; 13.1.4. North America Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 13.2. North America Pharmaceutical Drugs Market: Country Analysis; 13.3. USA Pharmaceutical Drugs Market; 13.3.1. USA Pharmaceutical Drugs Historic Market, 2012 - 2016; 13.3.2. USA Pharmaceutical Drugs Forecast Market, 2016 - 2020; 13.3.3 USA Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases13.3.4. USA Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 13.3.5. USA Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020;
14. South America Pharmaceutical Drugs Market;
14.1.1. South America Pharmaceutical Drugs Market Overview; 14.1.2. South America Pharmaceutical Drugs Historic Market, 2012 - 2016; 14.1.3. South America Pharmaceutical Drugs Forecast Market, 2016 - 2020; 14.1.4. South America Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 14.2. South America Pharmaceutical Drugs Market: Country Analysis; 14.3. Brazil Pharmaceutical Drugs Market; 14.3.1. Brazil Pharmaceutical Drugs Historic Market, 2012 - 2016; 14.3.2. Brazil Pharmaceutical Drugs Forecast Market, 2016 - 2020; 14.3.3. Brazil Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 14.3.4. Brazil Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 14.3.5. Brazil Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020;
15. Middle East Pharmaceutical Drugs Market;
15.1.1. Middle East Pharmaceutical Drugs Market Overview; 15.1.2. Middle East Pharmaceutical Drugs Historic Market, 2012 - 2016; 15.1.3. Middle East Pharmaceutical Drugs Forecast Market, 2016 - 2020; 15.1.4. Middle East Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases;
16. Africa Pharmaceutical Drugs Market;
16.1.1. Africa Pharmaceutical Drugs Market Overview; 16.1.2. Africa Pharmaceutical Drugs Historic Market, 2012 - 2016; 16.1.3. Africa Pharmaceutical Drugs Forecast Market, 2016 - 2020; 16.1.4. Africa Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases;
17. Pharmaceutical Drugs Market Competitive Landscape;
17.1. Company Profiles; 17.2. Johnson & Johnson; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Novartis Ag; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. F. Hoffmann-La Roche Ltd; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Pfizer Inc.; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Sanofi; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;
18. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market;
19. Market Background: Pharmaceuticals Market;
19.1.1. Pharmaceuticals Market Characteristics; 19.1.2. Pharmaceuticals Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceuticals Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceuticals Trends And Strategies; 19.2. Pharmaceuticals Market Regional And Country Analysis; 19.2.1. Global Pharmaceuticals Market, 2016, By Region; 19.2.2. Pharmaceuticals Market, 2016, By Country; 19.2.3. Pharmaceuticals Market, 2012 - 2020, Historic And Forecast, By Country; 19.2.4. Global Pharmaceuticals Market, Growth And Market Share Comparison, By Segment; 19.2.5. Global Pharmaceuticals Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Pharmaceuticals Market Comparison With Macro Economic Factors; 19.3.1. Pharmaceuticals Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Pharmaceuticals Expenditure, Global; 19.4. Pharmaceuticals Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceuticals Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceuticals Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceuticals Market;
20. Healthcare Industry Financial Margins;
21. Appendix;
21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer
